What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study

OBJECTIVES: Early phase cell therapy trials face many barriers to successful, timely completion. To optimise the conduct of a planned clinical trial of mesenchymal stem cell (MSC) therapy for chronic stroke, we sought patient and physician views on possible barriers and enablers that may influence t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalu, Manoj M, Foster, Madison, Presseau, Justin, Dowlatshahi, Dar, Castillo, Gisell, Cardenas, Analyssa, Tam, Whitney, Zlepnig, Jennifer, Timpson, Deborah, Dong, Yuan Yi, Juneau, Pascale, Fergusson, Dean A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Qualitative Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103795/
https://www.ncbi.nlm.nih.gov/pubmed/32198301
http://dx.doi.org/10.1136/bmjopen-2019-034354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103795/
https://www.ncbi.nlm.nih.gov/pubmed/32198301
http://dx.doi.org/10.1136/bmjopen-2019-034354

Ejemplares similares